News & Updates

Combined oral contraceptives and VTE: Which pill conveys the highest risk in young women?
Combined oral contraceptives and VTE: Which pill conveys the highest risk in young women?
29 Aug 2022
Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
29 Aug 2022

In the treatment of patients with severe COVID-19, adding the combination of pembrolizumab plus tocilizumab to standard of care (SOC) appears to result in higher and faster discharge from the hospital without sequelae, as shown in the proof-of-concept phase II COPERNICO trial.

Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
29 Aug 2022
Gout, hyperuricaemia meds less common among diabetics on SGLT2is
Gout, hyperuricaemia meds less common among diabetics on SGLT2is
28 Aug 2022

Patients with type 2 diabetes mellitus (T2DM) taking sodium-glucose cotransporter 2 inhibitors (SGLT2is) are less likely to be prescribed antigout or antihyperuricaemic drugs, a recent study has found.

Gout, hyperuricaemia meds less common among diabetics on SGLT2is
28 Aug 2022